Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-09

Clinical Trial Update: Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR) [NA]

View source ↗

Summary

Cilcare SAS's SAPHIR trial (NCT07083089) is actively recruiting to study hearing relevance in early-stage Alzheimer's and Parkinson's disease. The study include…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cilcare SAS | Conditions: Mild Cognitive Impairment (MCI) Amnestic, Parkinson Disease (PD) | NA | Status: RECRUITING